Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 475272-13-0 | MDL No. : | MFCD06795675 |
Formula : | C14H18BNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KUWMNVDETFAUDB-UHFFFAOYSA-N |
M.W : | 259.11 | Pubchem ID : | 17750239 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 73.97 |
TPSA : | 51.48 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.98 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.67 |
Log Po/w (WLOGP) : | 1.89 |
Log Po/w (MLOGP) : | 0.73 |
Log Po/w (SILICOS-IT) : | 1.75 |
Consensus Log Po/w : | 1.41 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.16 |
Solubility : | 0.178 mg/ml ; 0.000685 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.4 |
Solubility : | 0.102 mg/ml ; 0.000395 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.23 |
Solubility : | 0.0152 mg/ml ; 0.0000587 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.92 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 | UN#: | |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate In N,N-dimethyl-formamide at 0 - 20℃; for 1.5h; | 25.A A suspension of 357 mg (1.6 mmol) of 4-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)phenol and 650 mg (4.7 mmol) of KaCOs in 5 ml DMF was cooled to 0 °C and treated with220 |il (3.2 mmol) of bromoacetonitrile dropwise. The brown slurry was warmed to roomtemperature, stirred for 1.5 h, then was quenched with water (20 ml) and was extracted withbenzene (3X). The combined organic layers were dried over Na2SC>4, filtered, and the filtratewas concentrated and purified by chromatography on silica gel (hexanes : EtOAc, 17 : 3) togive the title compound. 'H-NMR (CDCl3) 5 1.34 (s, 12 H), 4.79 (s, 2 H), 6.96 (d, J=8.5Hz, 2H), 7.80 (d, J=8.5Hz, 2 H). Mass Spectrum (ESI) m/e = 260.2 (M+l, triplet). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | With potassium acetate In water; dimethyl sulfoxide | [4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetonitrile (15) [4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetonitrile (15) A solution of (4-iodophenoxy)acetonitrile (14e) (0.30 g, 1.16 mmol), bis(pinacolato)diboron (0.32 g, 1.27 mmol, 1.1 eqv), KOAc (0.34 g, 3.47 mmol, 3.0 eqv), and PdCl2dppf (5 mol %, 47 mg) in 4 ml of DMSO was stirred at 85° C. for 16 h. The mixture was added to H2O and extracted with CH2Cl2. The organic fractions were combined, back extracted with H2O, dried (MgSO4), filtered, and concentrated in vacuo. Column chromatography [Hexanes/EtOAc (2/1)] yielded 0.241 g of a white solid (80%): 1H NMR (400 MHz, CDCl3) δ1.34 (s, 12H), 4.79 (s, 2H), 6.97 (d, J=8.4 Hz, 2H), 7.81 (d, J=8.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ24.85, 53.18, 83.80, 114.03, 114.89, 136.79, 158.89; HRMS (EI) Calcd for C14H18BNO3: 258.1416. Found 258.1412. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With sodium hydroxide; sodium carbonate In 1,4-dioxane; methanol; 1,2-dimethoxyethane | 3-[4'-(carboxymethoxy)-1,1'-biphenyl-4-yl)propanoic acid (4) 3-[4'-(carboxymethoxy)-1,1'-biphenyl-4-yl)propanoic acid (4) [4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]acetonitrile (15) (55 mg, 0.21 mmol), 4-bromophenylhydrocinnamonitrile (44 mg, 0.21 mmol, 1 eqv), and Pd(PPh3)4 (5 mol %, 12 mg) were dissolved in 3 ml of DME. Na2CO3 (0.21 ml of 2 M aq solution, 0.42 mmol, 2 eqv) was added via syringe and the solution was stirred at 80° C. for 20 h. The reaction mixture was concentrated in vacuo and taken up in 2:1 H2O/CH2Cl2. The layers were separated and the water layer was extracted further with CH2Cl2. The combined organic fractions were dried (MgSO4), filtered, and concentrated in vacuo to yield a white solid. The crude solid was dissolved in 3/1 MeOH/dioxane. NaOH (1.5 ml of a 25% aq solution) was added and the mixture was stirred vigorously at 50° C. for 24 h. The solution was acidified to pH 1.0 with 1N HCl and extracted with EtOAc several times. The organics were combined, dried (MgSO4), filtered, and concentrated in vacuo to yield a white solid. This material was washed several times with CH2Cl2 to yield 59 mg of purified product (93%): 1H NMR (400 MHz, DMSO) δ2.56 (t, J=7.2 Hz, 2H), 2.84 (t, J=7.2 Hz, 2H), 4.71 (s, 2H), 6.98 (d, J=8.8 Hz, 2H), 7.28 (d, J=8.4 Hz, 2H), 7.52 (d, J=8.0 Hz, 2H), 7.56 (d, J=8.8 Hz, 2H); 13C NMR (125 MHz, DMSO) δ29.84, 35.07, 64.41, 114.75, 126.05, 127.46, 128.69, 132.66, 137.42, 139.37, 157.13, 170.10, 173.68; HRMS (EI) Calcd for C17H16O5: 300.0998. Found 300.1003. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With dmap; copper diacetate In acetonitrile at 80℃; for 96h; Molecular sieves; | 93.1 Copper(II)acetate (26 mg), 4-cyanomethoxy-phenylboronic acid pinacol ester (CAS Reg. No. 475272-13-0, 38 mg), and DMAP (30 mg) were added to a solution of 5-[2-(2-chloro-4-hydroxy-phenyl)-1-hydroxy-1-trifluoromethyl-propyl]-1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one (Example 85, 20 mg) in acetonitrile (3 ml). The mixture was stirred with molecular sieves under air atmosphere for 4 h at 80° C., and then filtered over Celite concentrated to an oil. The residue was purified by prep. HPLC (C18-column, solvent gradient 20-98% CH3CN in 0.1% HCOOH[aq]) to give the title compound (24 mg) as a white solid. MS (m/e)=546.1 [M+H+]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane for 18h; Inert atmosphere; Reflux; | 2-11 3-[2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanenitrile General procedure: (3) Under a nitrogen gas atmosphere, at room temperature in 1,4-dioxane (10 mL) solution of 3- (4-bromo-2-chlorophenyl) propanenitrile (1.00 g), bis (pinacolato) diboron (1.14 g) , [1,1'-bis (diphenylphosphino) ferrocene] palladium (II) dichloride dichloromethane complex (1: 1) (167 mg) and successively added potassium acetate (0.80 g), was heated under reflux for 18 hours. The reaction solution was cooled to room temperature, the reaction mixture was poured into water and extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, after filtration, concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane: ethyl acetate = 5: 1) to give the title compound (1.06 g, 89%) as a colorless solid. |
[ 936250-18-9 ]
2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.98
[ 936250-19-0 ]
2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.95
[ 1256359-92-8 ]
2-(5-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.94
[ 1256359-92-8 ]
2-(5-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.94
[ 1147105-68-7 ]
2-(4-Ethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.93
[ 936250-18-9 ]
2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.98
[ 936250-19-0 ]
2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.95
[ 1256359-92-8 ]
2-(5-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.94
[ 1147105-68-7 ]
2-(4-Ethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.93
[ 936250-18-9 ]
2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.98
[ 936250-19-0 ]
2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.95
[ 1256359-92-8 ]
2-(5-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.94
[ 1147105-68-7 ]
2-(4-Ethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.93
[ 936250-18-9 ]
2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.98
[ 936250-19-0 ]
2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.95
[ 1256359-92-8 ]
2-(5-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.94
[ 1147105-68-7 ]
2-(4-Ethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.93
[ 936250-18-9 ]
2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.98
[ 936250-19-0 ]
2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.95
[ 1256359-92-8 ]
2-(5-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)acetonitrile
Similarity: 0.94